Clinical Trials Directory

Trials / Completed

CompletedNCT05846139

Slow-release Locally Administered 0.02% Hypochlorite Formulation

The Effectiveness of an Incremental Approach to Nonsurgical Periodontal Therapy With the Use of Adjunctive Slow-release Locally Administered 0.02% Hypochlorite Formulation: A Single-blind Randomized Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Tuscan Dental Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Aim: The presence of bacterial plaque is associated with the development of periodontal inflammation. The aim of this single-blind randomized clinical study was to prospectively evaluate the efficacy of two different agents in a staged approach for nonsurgical periodontal treatment in terms of clinical and patients related outcomes in a cohort of patients with periodontitis: NitrAdine® based disinfectant formula (PerioTabs®) vs Chlorhexidine 0.12 toothpaste and mouthwash 0.20. Material and methods: Patients with a diagnosis of periodontal disease (stage I-III) scheduled for non surgical periodontal treatment were randomly allocated to the preparatory home use of a chlorhexidine mouthwash or a NitrAdine® based brushing solution called PerioTabs® for 10-15 days. Active decontamination with ultrasonic scalers was performed after the completion of the preparation period. Clinical and patient-related outcomes were recorded at baseline, at the moment of professional intervention, and after 30 and 90 days from baseline.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTPerioTabs® brushing solutionPerioTabs® contains a non-antibiotic biofilm removal complex called NitrAdine®.Its anti-biofilm action is based on the combination of surfactant-induced protein denaturation and slow release of a non-toxic concentration of hypochlorite (0.02%).
COMBINATION_PRODUCTChlorhexidine 0.12 %chlorhexidine 0.12 % toothpaste and chlorhexidine 0.2% mouth rinse

Timeline

Start date
2022-01-17
Primary completion
2022-11-21
Completion
2022-11-21
First posted
2023-05-06
Last updated
2023-05-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05846139. Inclusion in this directory is not an endorsement.